Kinase regulation by sulfur and selenium containing compounds.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Cancer Drug Targets

• Publication date

  2011-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/156800911795538093PMID 21395545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk.

  2011cited by this paper
• Azole-based inhibitors of AKT/PKB for the treatment of cancer.

  2010cited by this paper
• Tumor inhibition by sodium selenite is associated with activation of c‐Jun NH2‐terminal kinase 1 and suppression of β‐catenin signaling

  2010cited by this paper
• Selectively nonselective kinase inhibition: striking the right balance.

  2010cited by this paper
• A novel DNA intercalator, butylamino-pyrimido[4′,5′:4,5]selenolo(2,3-b)quinoline, induces cell cycle arrest and apoptosis in leukemic cells

  2010cited by this paper
• Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma.

  2010cited by this paper
• Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study

  2010cited by this paper
• Design, synthesis and evaluation of (E)-alpha-benzylthio chalcones as novel inhibitors of BCR-ABL kinase.

  2010cited by this paper
• (Pre-)clinical pharmacology and activity of pazopanib, a novel multikinase angiogenesis inhibitor.

  2010cited by this paper
• Sodium selenite inhibits the expression of VEGF, TGFbeta(1) and IL-6 induced by LPS in human PC3 cells via TLR4-NF-(K)B signaling blockage.

  2010cited by this paper
• Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer.

  2010cited by this paper
• Janus-activated kinases and signal transducer and activator of transcription control tumor growth response to camptothecin in human colon cancer cells

  2010cited by this paper
• Enhanced Nrf2-dependent induction of glutathione in mouse embryonic fibroblasts by isoselenocyanate analog of sulforaphane.

  2010cited by this paper
• Nuclear Phospho-Akt Increase Predicts Synergy of PI3K Inhibition and Doxorubicin in Breast and Ovarian Cancer

  2010cited by this paper
• Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16/18-infected cancer cells

  2010cited by this paper
• Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors.

  2010cited by this paper
• Pazopanib

  2010cited by this paper
• Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines

  2010cited by this paper
• Signaling functions of reactive oxygen species.

  2010cited by this paper
• Hybrid anticancer agents: isothiocyanate-progesterone conjugates as chemotherapeutic agents and insights into their cytotoxicities.

  2010cited by this paper
• The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity

  2010cited by this paper
• Synthesis and in vitro Anticancer Activities of some Selenadiazole Derivatives

  2010cited by this paper
• Src inhibitors in lung cancer: current status and future directions.

  2010cited by this paper
• Effects of phenylethyl isothiocyanate and its metabolite on cell-cycle arrest and apoptosis in LNCaP human prostate cancer cells

  2010cited by this paper
• Kinetics of ERK1/2 activation determine sensitivity of acute myeloid leukaemia cells to the induction of apoptosis by the novel small molecule ingenol 3-angelate (PEP005)

  2010cited by this paper
• Sulforaphane protects against cisplatin-induced nephrotoxicity.

  2010cited by this paper
• Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo.

  2010cited by this paper
• Sulforaphane Inhibits Constitutive and Interleukin-6–Induced Activation of Signal Transducer and Activator of Transcription 3 in Prostate Cancer Cells

  2010cited by this paper
• Molecular therapy of pancreatic cancer.

  2010cited by this paper
• Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.

  2010cited by this paper
• Energy Restriction as an Antitumor Target of Thiazolidinediones*

  2010cited by this paper
• SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo

  2010cited by this paper
• Molecular Pharmacology and Antitumor Activity of PHT-427, a Novel Akt/Phosphatidylinositide-Dependent Protein Kinase 1 Pleckstrin Homology Domain Inhibitor

  2010cited by this paper
• Prostate cancer chemopreventive activity of phenethyl isothiocyanate through epigenetic regulation (review).

  2010cited by this paper
• Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancer.

  2010cited by this paper
• Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo

  2010cited by this paper
• Akt-dependent and -independent mechanisms of mTOR regulation in cancer.

  2009cited by this paper
• Synthesis and biological evaluation of 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as a novel class of potential anti-tumor agents.

  2009cited by this paper
• Effects of two organotin(IV)(sulfonatophenyl)porphinates on MAPKs and on the growth of A375 human melanoma cells.

  2009cited by this paper
• Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells.

  2009cited by this paper
• Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase‐2 inhibitor celecoxib

  2009cited by this paper
• Thiazolidinediones Mimic Glucose Starvation in Facilitating Sp1 Degradation through the Up-Regulation of β-Transducin Repeat-Containing Protein

  2009cited by this paper
• Modulation of ionizing radiation-induced G2 arrest by cyclooxygenase-2 and its inhibitor celecoxib.

  2009cited by this paper
• 2-Aminobenzimidazoles as potent Aurora kinase inhibitors.

  2009cited by this paper
• Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients

  2009cited by this paper
• Molecular mechanism of diallyl disulfide in cell cycle arrest and apoptosis in HCT‐116 colon cancer cells

  2009cited by this paper
• TOR Complex 2 Controls Gene Silencing, Telomere Length Maintenance, and Survival under DNA-Damaging Conditions

  2009cited by this paper
• The selenium analog of the chemopreventive compound S,S'-(1,4-phenylenebis[1,2-ethanediyl])bisisothiourea is a remarkable inducer of apoptosis and inhibitor of cell growth in human non-small cell lung cancer.

  2009cited by this paper
• Synthesis and Pharmacological Screening of Several Aroyl and Heteroaroyl Selenylacetic Acid Derivatives as Cytotoxic and Antiproliferative Agents

  2009cited by this paper
• Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells.

  2009cited by this paper
• How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?

  2009cited by this paper
• Cyclin‐dependent kinase 1 inhibitor RO‐3306 enhances p53‐mediated Bax activation and mitochondrial apoptosis in AML

  2009cited by this paper
• Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes

  2009cited by this paper
• The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model

  2009cited by this paper
• Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab

  2009cited by this paper
• The regulatory effect of the p38 signaling pathway on valdecoxib-induced apoptosis of the Eca109 cell line.

  2009cited by this paper
• Cancer driver mutations in protein kinase genes.

  2009cited by this paper
• Sulforaphane inhibits angiogenesis through activation of FOXO transcription factors.

  2009cited by this paper
• Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases.

  2009cited by this paper
• Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis

  2009cited by this paper
• Effects of Selenite and Genistein on G2/M Cell Cycle Arrest and Apoptosis in Human Prostate Cancer Cells

  2009cited by this paper
• Targeting cancer with small molecule kinase inhibitors

  2009cited by this paper
• Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells.

  2009cited by this paper
• Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma.

  2009cited by this paper
• Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellular-regulated kinase 1/2 pathway and other cancer signaling genes.

  2009cited by this paper
• Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases.

  2009cited by this paper
• Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer.

  2009cited by this paper
• In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes

  2009cited by this paper
• Rapid Development of Hypertension by Sorafenib: Toxicity or Target?

  2009cited by this paper
• Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells.

  2009cited by this paper
• Induction of apoptosis in a human leukemic cell line via reactive oxygen species modulation by antioxidants.

  2009cited by this paper
• Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells.

  2009cited by this paper
• Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model

  2009cited by this paper
• RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer.

  2009cited by this paper
• Antineoplastic effect of proliferation signal inhibitors: from biology to clinical application.

  2009cited by this paper
• Advances in Aurora kinase inhibitor patents

  2009cited by this paper
• Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates

  2009cited by this paper
• Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells

  2009cited by this paper
• Apoptosis induction in human lung adenocarcinoma cells by oil‐soluble allyl sulfides: Triggers, pathways, and modulators

  2009cited by this paper
• Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor‐κB

  2009cited by this paper
• Sodium Selenite Increases the Activity of the Tumor Suppressor Protein, PTEN, in DU-145 Prostate Cancer Cells

  2009cited by this paper
• Cyclin-dependent kinase inhibitors as potential targeted anticancer agents

  2009cited by this paper
• In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma.

  2009cited by this paper
• Axitinib—a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor

  2009cited by this paper
• Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines

  2009cited by this paper
• Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941

  2009cited by this paper
• Activity of the multikinase inhibitor dasatinib against ovarian cancer cells

  2009cited by this paper
• Activation of several concurrent proapoptic pathways by sulforaphane in human colon cancer cells SW620.

  2009cited by this paper
• Role of Mitogen-Activated Protein Kinase Sty1 in Regulation of Eukaryotic Initiation Factor 2α Kinases in Response to Environmental Stress in Schizosaccharomyces pombe

  2009cited by this paper
• A COX-2 inhibitor nimesulide analog selectively induces apoptosis in Her2 overexpressing breast cancer cells via cytochrome c dependent mechanisms.

  2009cited by this paper
• SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples

  2009cited by this paper
• The anticancer effects of sodium selenite and selenomethionine on human colorectal carcinoma cell lines in nude mice.

  2009cited by this paper
• Diallyl trisulfide selectively causes Bax‐ and Bak‐mediated apoptosis in human lung cancer cells

  2009cited by this paper
• Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions.

  2009cited by this paper
• Targeting multiple kinases in glioblastoma multiforme.

  2009cited by this paper
• Synthesis and evaluation of pyrido-thieno-pyrimidines as potent and selective Cdc7 kinase inhibitors.

  2009cited by this paper
• Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells.

  2009cited by this paper
• Exploitation of protein kinase C: a useful target for cancer therapy.

  2009cited by this paper
• Diallyl sulfide inhibits murine WEHI-3 leukemia cells in BALB/c mice in vitro and in vivo

  2009cited by this paper
• The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells.

  2009cited by this paper

• Nanotechnology-driven coordination of shoot-root systems enhances rice nitrogen use efficiency.

  2025cites this paper
• Seed and foliar application of nano-selenium improves sesame triacylglycerols and oil yield via photosynthetic pigment and enzymatic and chemical antioxidant enhancement revealed by spectrophotometric, UHPLC-analysis and chemometric modeling

  2024cites this paper
• Studies on the selective synthesis of diorganyl diselenides using potassium hydroxide and mechanistic investigations of the reaction pathway.

  2024cites this paper
• The effects of Mineral Waters from Slănic Moldova's Spring 1 and Spring 1 bis on Fibroblast activity: An In Vitro Study

  2023cites this paper
• Synthesis and Characterization of Sulfur and Sulfur-Selenium Nanoparticles Loaded on Reduced Graphene Oxide and Their Antibacterial Activity against Gram-Positive Pathogens

  2022cites this paper
• Density functional theory study towards capability of Ga-doped boron nitride nanosheet as a nanocarrier for 3-allyl-2 selenohydantoin anticancer drug delivery

  2021cites this paper
• Synthesis of sp2-Iminosugar Selenoglycolipids as Multitarget Drug Candidates with Antiproliferative, Leishmanicidal and Anti-Inflammatory Properties

  2021cites this paper
• Molecular simulation of the (GPx)-like antioxidant activity of ebselen derivatives through machine learning techniques

  2021cites this paper
• Morphological and Immunohistochemical Features of the Heart under the Effect of Hydrogen Sulfide Balneotherapy

  2021cites this paper
• Synthesis and anticancer activity of bis(2-arylimidazo[1,2-a]pyridin-3-yl) selenides and diselenides: the copper-catalyzed tandem C–H selenation of 2-arylimidazo[1,2-a]pyridine with selenium

  2020cites this paper
• Release of reactive selenium species from phthalic selenoanhydride in the presence of hydrogen sulfide and glutathione with implications for cancer research

  2019cites this paper
• Strategies for the development of selenium-based anticancer drugs.

  2018cites this paper
• Selenides and Diselenides: A Review of Their Anticancer and Chemopreventive Activity

  2018cites this paper
• Aguas sulfuradas y dermatología

  2017cites this paper
• Sulphurous Mineral Waters: New Applications for Health

  2017cites this paper
• Recent advances in the chemistry of selenium-containing heterocycles: Five-membered ring systems

  2016cites this paper
• Synthesis, isomerization and biological activity of novel 2-selenohydantoin derivatives.

  2016cites this paper
• Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer

  2015cites this paper
• Selenium-Functionalized Molecules (SeFMs) as Potential Drugs and Nutritional Supplements

  2015cites this paper
• Uptake and efflux of rhenium in cells exposed to rhenium diseleno-ether and tissue distribution of rhenium and selenium after rhenium diseleno-ether treatment in mice.

  2014cites this paper
• Post SELECT: selenium on trial.

  2013cites this paper
• Synthesis and evaluation of diaryl sulfides and diaryl selenide compounds for antitubulin and cytotoxic activity.

  2013cites this paper
• Selenium Compounds, Apoptosis and Other Types of Cell Death: An Overview for Cancer Therapy

  2012cites this paper
• Biological responses related to agonistic, antagonistic and synergistic interactions of chemical species

  2012cites this paper
• Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastases.

  2012cites this paper
• The modifying effect of selenium and vitamins A, C, and E on the genotoxicity induced by sunset yellow in male mice.

  2012cites this paper
• Nutrition and the psychoneuroimmunology of postpartum depression

  2012cites this paper
• Anti‐cancer potential of selenium‐ and tellurium‐containing species: opportunities abound!

  2012cites this paper
• Novel Library of Selenocompounds as Kinase Modulators

  2011cites this paper
• Selenium and clinical trials: new therapeutic evidence for multiple diseases.

  2011cites this paper